Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04274790

Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer

Analysis of the Impact of 5-Fluorouracil on the Translational Control and Plasticity of Cancer Cells From Liver Metastases of Colon Cancer

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Centre Leon Berard · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Analyze the dynamics of incorporation of 5-fluorouracil into cancer cell ribosomes from liver metastases of patient with metastatic colon cancer.

Detailed description

This is a monocentric, prospective, non-interventional cohort study in adult patients with metastatic colon cancer with hepatics metastasis. Tumour samples collected for this study include: * A fragment of the previously operated primary tumor: FFIP block and/or archived frozen tumor if available. * A fragment of the liver metastasis(s) performed as part of standard metastasis surgery, this fragment will include a tumor area and a healthy area within the margin of excision. These samples collected in a fresh state will be analyzed immediately.

Conditions

Interventions

TypeNameDescription
PROCEDUREScheduled and planned surgeryCollection of tumour samples from samples collected as part of standard patient management. Diagnostic pathological analysis will be a priority. These samples will be taken by experienced staff during the hospital visit scheduled as part of standard care.

Timeline

Start date
2021-06-01
Primary completion
2023-03-01
Completion
2023-03-01
First posted
2020-02-18
Last updated
2024-02-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04274790. Inclusion in this directory is not an endorsement.